Skip to main content

1 Result(s)

within I. Rabinowitz Remove this filter Oncology Remove this filter

and

  1. No Access

    Article

    Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies

    Purpose: This phase I trial assessed the safety and the maximum tolerated dose of capecitabine given for 10 days prior to a combination of cisplatin and irinotecan in patients with advanc...

    H. Sayar, Z. Shen, S. J. Lee, M. Royce, I. Rabinowitz, F. Lee… in Investigational New Drugs (2009)